Artery Research

Volume 14, Issue C, June 2016, Pages 27 - 35

Combination therapy in hypertension: From effect on arterial stiffness and central haemodynamics to cardiovascular benefits☆

Authors
Charalambos Vlachopoulos*
Hypertension Unit and Peripheral Vessels Unit, 1st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece

This article was presented as lecture in the symposium on “Arterial stiffness: a translational approach” at the ARTERY 14 Congress in Maastricht, The Netherlands (October 9–11, 2014).

*1st Cardiology Department, Athens Medical School, Hippokration Hospital, Profiti Elia 24, Athens 14575, Greece. Tel.: +30 697 227 2727. E-mail address: cvlachop@otenet.gr
Corresponding Author
Charalambos Vlachopoulos
Received 28 January 2016, Revised 6 February 2016, Accepted 9 February 2016, Available Online 5 March 2016.
DOI
10.1016/j.artres.2016.02.005How to use a DOI?
Keywords
Aortic stiffness; Pulse wave velocity; Wave reflections; Central haemodynamics; Hypertension; Angiotensin converting enzyme inhibitors; Calcium channel blockers
Abstract

Measures of arterial aging have the potential to improve risk prediction beyond traditional risk scores. Such biomarkers that fulfil most, or some of the strict criteria of a surrogate end-point are aortic stiffness (IIa level of recommendation in European Guidelines and Position Papers) and central haemodynamics (IIb level of recommendation). Early intervention towards improving aortic elastic properties acquires particular importance since evidence suggests that arterial stiffening may occur before the onset of hypertension. Part of the beneficial effects of antihypertensive treatment in risk reduction may be mediated through improvement in aortic stiffness and central haemodynamics. However, not all antihypertensive drugs affect aortic stiffness and central haemodynamics in a similar way. Angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB) and calcium channel blockers (CCB) have beneficial effects on such parameters. Meta-analytical approaches have shown that ACE inhibitors reduce mortality in hypertension, whereas ARBs do not exhibit such a benefit. Furthermore, ACE inhibitors have been shown to reduce the risk of coronary artery disease, and CCBs to reduce the risk of stroke independently of blood pressure reduction. Combining an ACE inhibitor with a CCB has the potential to reduce cardiovascular risk (synergy at the clinical level) by reducing aortic stiffness and improving central haemodynamics (synergy at the vascular level).

Copyright
© 2016 Published by Elsevier B.V. on behalf of Association for Research into Arterial Structure and Physiology.
Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)
View full text (HTML)

Journal
Artery Research
Volume-Issue
14 - C
Pages
27 - 35
Publication Date
2016/03/05
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2016.02.005How to use a DOI?
Copyright
© 2016 Published by Elsevier B.V. on behalf of Association for Research into Arterial Structure and Physiology.
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - Charalambos Vlachopoulos
PY  - 2016
DA  - 2016/03/05
TI  - Combination therapy in hypertension: From effect on arterial stiffness and central haemodynamics to cardiovascular benefits☆
JO  - Artery Research
SP  - 27
EP  - 35
VL  - 14
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2016.02.005
DO  - 10.1016/j.artres.2016.02.005
ID  - Vlachopoulos2016
ER  -